Cargando…
Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190516/ https://www.ncbi.nlm.nih.gov/pubmed/34136234 http://dx.doi.org/10.1002/ccr3.4218 |
_version_ | 1783705700567875584 |
---|---|
author | Frankel, Arthur E. Yip, Wai C. Naik, Eknath Hasselbalch, Hans C. |
author_facet | Frankel, Arthur E. Yip, Wai C. Naik, Eknath Hasselbalch, Hans C. |
author_sort | Frankel, Arthur E. |
collection | PubMed |
description | A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19. |
format | Online Article Text |
id | pubmed-8190516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81905162021-06-15 Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus Frankel, Arthur E. Yip, Wai C. Naik, Eknath Hasselbalch, Hans C. Clin Case Rep Case Reports A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19. John Wiley and Sons Inc. 2021-06-09 /pmc/articles/PMC8190516/ /pubmed/34136234 http://dx.doi.org/10.1002/ccr3.4218 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Frankel, Arthur E. Yip, Wai C. Naik, Eknath Hasselbalch, Hans C. Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
title | Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
title_full | Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
title_fullStr | Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
title_full_unstemmed | Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
title_short | Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
title_sort | response to pegylated interferon in a covid‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190516/ https://www.ncbi.nlm.nih.gov/pubmed/34136234 http://dx.doi.org/10.1002/ccr3.4218 |
work_keys_str_mv | AT frankelarthure responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus AT yipwaic responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus AT naikeknath responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus AT hasselbalchhansc responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus |